Literature DB >> 14998501

Perinatal tuberculosis and HIV-1: considerations for resource-limited settings.

T Pillay1, M Khan, J Moodley, M Adhikari, H Coovadia.   

Abstract

Tuberculosis is the commonest HIV-1-related disease and the most frequent cause of mortality in young women in endemic regions. Tuberculosis and HIV-1 are independent risk factors for maternal mortality and adverse perinatal outcomes, and in combination have a greater impact on these parameters than their individual effects. In referral health centres in southern Africa around one-sixth of all maternal deaths are due to tuberculosis/HIV-1 coinfection. One-third (37%) of HIV-1-infected mothers with tuberculosis are severely immunocompromised, with CD4 counts of fewer than 200 cells/microL compared with 14-19% in mothers recruited into major mother-to-child intervention trials in Europe. Babies born to mothers with tuberculosis/HIV-1 also have higher rates of prematurity, low birthweight, and intrauterine growth restriction. Transmission rates of HIV-1 from mother to infant are around 25-45% in resource-limited settings, while that for mother-to-child-transmission of tuberculosis is 15% within 3 weeks of birth. We highlight this emergent problem, and discuss the dilemmas associated with diagnosis and management of pregnant HIV-1-infected mothers with tuberculosis, and their newborn babies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998501     DOI: 10.1016/S1473-3099(04)00939-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  21 in total

1.  Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study.

Authors:  Faheem G Sheriff; Karim P Manji; Mohamed P Manji; Mohamedsuhel M Chagani; Rose M Mpembeni; Ahmed M Jusabani; Zaheerabbas R Alwani; Taha S Karimjee
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090

2.  Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.

Authors:  Amita Gupta; Ramesh Bhosale; Arti Kinikar; Nikhil Gupte; Renu Bharadwaj; Anju Kagal; Suvarna Joshi; Medha Khandekar; Alaka Karmarkar; Vandana Kulkarni; Jayagowri Sastry; Vidya Mave; Nishi Suryavanshi; Madhuri Thakar; Smita Kulkarni; Srikanth Tripathy; Pradeep Sambarey; Sandesh Patil; Ramesh Paranjape; Robert C Bollinger; Arun Jamkar
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

3.  Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

Authors:  Amita Gupta; Grace Montepiedra; Lisa Aaron; Gerhard Theron; Katie McCarthy; Sarah Bradford; Tsungai Chipato; Tichaona Vhembo; Lynda Stranix-Chibanda; Carolyne Onyango-Makumbi; Gaerolwe R Masheto; Avy Violari; Blandina T Mmbaga; Linda Aurpibul; Ramesh Bhosale; Vidya Mave; Vanessa Rouzier; Anneke Hesseling; Katherine Shin; Bonnie Zimmer; Diane Costello; Timothy R Sterling; Nahida Chakhtoura; Patrick Jean-Philippe; Adriana Weinberg
Journal:  N Engl J Med       Date:  2019-10-03       Impact factor: 91.245

4.  Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection.

Authors:  Hongliang Yang; JoLynn Troudt; Ajay Grover; Kimberly Arnett; Megan Lucas; Yun Sang Cho; Helle Bielefeldt-Ohmann; Jennifer Taylor; Angelo Izzo; Karen M Dobos
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

5.  Infantile pulmonary tuberculosis: the great mimic.

Authors:  Roma Subhash Varik; Attibele Mahadevaiah Shubha; Maria Lewin; Betty Alexander; Usha Kini; Kanishka Das
Journal:  Pediatr Surg Int       Date:  2012-04-21       Impact factor: 1.827

6.  Latent tuberculosis in a newborn: diagnostic challenges.

Authors:  Iris De Schutter; Kinda Schepers; Mahavir Singh; Françoise Mascart; Anne Malfroot
Journal:  Eur J Pediatr       Date:  2010-04-22       Impact factor: 3.183

7.  Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

Authors:  Amita Gupta; Jyoti S Mathad; Susan M Abdel-Rahman; Jessica D Albano; Radu Botgros; Vikki Brown; Renee S Browning; Liza Dawson; Kelly E Dooley; Devasena Gnanashanmugam; Beatriz Grinsztejn; Sonia Hernandez-Diaz; Patrick Jean-Philippe; Peter Kim; Anne D Lyerly; Mark Mirochnick; Lynne M Mofenson; Grace Montepiedra; Jeanna Piper; Leyla Sahin; Radojka Savic; Betsy Smith; Hans Spiegel; Soumya Swaminathan; D Heather Watts; Amina White
Journal:  Clin Infect Dis       Date:  2015-12-09       Impact factor: 9.079

8.  Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health.

Authors:  Andrea Deluca; Richard E Chaisson; Neil A Martinson
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

9.  Tuberculosis and the obstetrician-gynecologist: a global perspective.

Authors:  Rose L Molina; Khady Diouf; Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2013

10.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.